GTCR LLC (auto-surfaced)
cloneable
· 31-DEC-2025 → 31-MAR-2026
AUM $3,781,393,104 · 6 positions · top-10 100.0%
· SEC filing history →
13FScore 22/100 — cloning their disclosed top holdings over ~4.7y returned -12%/yr vs S&P +10%/yr (alpha -22%/yr), ahead of the market in 37% of quarters. Cloneable 13F equity book only — excludes hedges/shorts/non-US.
New positions
| Issuer | % book | Value | Since entry | Conviction | Business | Tags |
|---|
| $GPN · GLOBAL PMTS INC | 77.0% | $2,911,939,173 | +16% | High | Global Payments provides payment technology and software services, including merchant acquiring, processing, and issuer solutions for merchants, financial institutions, and businesses worldwide. | S&P |
| $AJG · GALLAGHER ARTHUR J & CO | 13.6% | $514,111,756 | +17% | High | Arthur J. Gallagher & Co. is a global insurance brokerage and risk-management firm that provides insurance and reinsurance brokerage and consulting services to businesses and organizations. | S&P |
Added to (≥+25% shares)
| Issuer | % book | Δ shares | Since add | Conviction | Business | Tags |
|---|
| none |
Top holdings now
| Issuer | % book | Since entry | Business | Tags |
|---|
| $GPN · GLOBAL PMTS INC | 77.0% | +16% Q1 '26 | Global Payments provides payment technology and software services, including merchant acquiring, processing, and issuer solutions for merchants, financial institutions, and businesses worldwide. | S&P |
| $AJG · GALLAGHER ARTHUR J & CO | 13.6% | +17% Q1 '26 | Arthur J. Gallagher & Co. is a global insurance brokerage and risk-management firm that provides insurance and reinsurance brokerage and consulting services to businesses and organizations. | S&P |
| $SHC · SOTERA HEALTH CO | 4.8% | -26% ≥Q2 '21 | Sotera Health provides outsourced sterilization, lab testing and advisory services to medical device and pharmaceutical companies through its Sterigenics, Nordion and Nelson Labs businesses. | NASDAQ |
| $GOGO · GOGO INC | 2.5% | -69% ≥Q2 '21 | | NASDAQ |
| $MRVI · MARAVAI LIFESCIENCES HLDGS I | 1.5% | -84% ≥Q2 '21 | Nucleic-acid production for biopharma (mRNA) | NASDAQ |
| $SEAT · VIVID SEATS INC | 0.6% | -2% Q4 '25 | | NASDAQ |